601 related articles for article (PubMed ID: 12555013)
1. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
2. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
5. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
Testoni PA; Mariani A; Masci E; Curioni S
Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
Das A; Singh P; Sivak MV; Chak A
Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513
[TBL] [Abstract][Full Text] [Related]
7. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
10. New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines.
Demols A; Deviere J
JOP; 2003 Jan; 4(1):49-57. PubMed ID: 12555016
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
[TBL] [Abstract][Full Text] [Related]
12. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
13. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video).
Bailey AA; Bourke MJ; Kaffes AJ; Byth K; Lee EY; Williams SJ
Gastrointest Endosc; 2010 Feb; 71(2):266-71. PubMed ID: 20003969
[TBL] [Abstract][Full Text] [Related]
14. Risk for post-ERCP pancreatitis after needle knife precut sphincterotomy following repeated cannulation attempts.
Lee JK; Park JK; Yoon WJ; Lee SH; Lee KH; Ryu JK; Kim YT; Yoon YB
J Clin Gastroenterol; 2007 Apr; 41(4):427-31. PubMed ID: 17413615
[TBL] [Abstract][Full Text] [Related]
15. Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication.
Testoni PA
JOP; 2002 Nov; 3(6):195-201. PubMed ID: 12432186
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results.
Saad AM; Fogel EL; McHenry L; Watkins JL; Sherman S; Lazzell-Pannell L; Lehman GA
Gastrointest Endosc; 2008 Feb; 67(2):255-61. PubMed ID: 18028920
[TBL] [Abstract][Full Text] [Related]
17. Post-ERCP pancreatitis.
Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological prevention of post-ERCP pancreatitis: which therapy is best?
Mariani A
JOP; 2003 Jan; 4(1):68-74. PubMed ID: 12555018
[TBL] [Abstract][Full Text] [Related]
19. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Freeman ML
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
